Mitochondrial Dysfunction in Psychiatric Disorders

Part of the Oxidative Stress in Applied Basic Research and Clinical Practice book series (OXISTRESS)


Psychiatric disorders represent a large class of medical disorders with unclear etiologies and limited effective treatments. Mitochondrial dysfunction is particularly interesting as it can manifest a wide variety of symptoms including abnormalities in central nervous system functioning with focal neurological, cognitive, behavioral, and psychiatric symptoms. Evidence has started to accumulate that mitochondrial dysfunction plays a role in schizophrenia, major depression, bipolar disorder, personality/mood disorders, Alzheimer’s disease, and autism spectrum disorders. The prevalence of mitochondrial dysfunction in these disorders is not clear. Studies reporting laboratory testing for the identification of mitochondrial dysfunction and treatments in these disorders are generally lacking. Notably, the identification of mitochondrial dysfunction in psychiatric conditions could lead to the development of better medications and other treatments for these conditions that target specific metabolic abnormalities. Although the evidence for mitochondrial dysfunction in psychiatric disorders is increasing, additional studies are warranted.


Autism Spectrum Disorder Autism Spectrum Disorder Psychiatric Disorder Bipolar Disorder Mitochondrial Dysfunction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Adenosine diphosphate


Autism spectrum disorder


Adenosine triphosphate


Central nervous system


Electron transport chain


Flavin adenine dinucleotide




Mitochondrial disorder


Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes


Mitochondrial DNA




Nicotinamide adenine dinucleotide


Nuclear DNA


Obsessive-compulsive disorder


Polymerase gamma-1


Reactive oxygen species


Tricarboxylic acid


  1. Adams JB, Holloway C (2004) Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med 10(6):1033–1039PubMedGoogle Scholar
  2. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E et al (2011) Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr 11:111PubMedCentralPubMedGoogle Scholar
  3. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y et al (2005) Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58(2):85–96PubMedGoogle Scholar
  4. Ames A 3rd (2000) CNS energy metabolism as related to function. Brain Res Brain Res Rev 34(1–2):42–68PubMedGoogle Scholar
  5. Anderson MP, Hooker BS, Herbert MR (2008) Bridging from cells to cognition in autism pathophysiology: biological pathways to defective brain function and plasticity. Am J Biochem Biotechnol 4(2):167–176Google Scholar
  6. Andreazza AC, Shao L, Wang JF, Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67(4):360–368PubMedGoogle Scholar
  7. Anglin RE, Garside SL, Tarnopolsky MA, Mazurek MF, Rosebush PI (2012a) The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. J Clin Psychiatry 73(4):506–512PubMedGoogle Scholar
  8. Anglin RE, Mazurek MF, Tarnopolsky MA, Rosebush PI (2012b) The mitochondrial genome and psychiatric illness. Am J Med Genet B Neuropsychiatr Genet 159B(7):749–759PubMedGoogle Scholar
  9. Bloch Y, Applebaum J, Osher Y, Amar S, Azab AN, Agam G et al (2012) Normobaric hyperoxia treatment of schizophrenia. J Clin Psychopharmacol 32(4):525–530PubMedGoogle Scholar
  10. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57(5):695–703PubMedGoogle Scholar
  11. Bubber P, Hartounian V, Gibson GE, Blass JP (2011) Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol 21(3):254–260PubMedCentralPubMedGoogle Scholar
  12. Burke MG, Miller MD (2011) Practical guidelines for evaluating lead exposure in children with mental health conditions: molecular effects and clinical implications. Postgrad Med 123(1):160–168PubMedGoogle Scholar
  13. Calabrese V, Lodi R, Tonon C, D’Agata V, Sapienza M, Scapagnini G et al (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich’s ataxia. J Neurol Sci 233(1–2):145–162PubMedGoogle Scholar
  14. Castro-Gago M, Blanco-Barca O, Gomez-Lado C, Pintos-Martinez E, Campos-Gonzalez Y, Eiris-Punal J (2008) Association between autistic spectrum and mitochondrial pathology. Rev Neurol 47(1):52–53PubMedGoogle Scholar
  15. Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L et al (1995) Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29(1):217–224PubMedGoogle Scholar
  16. Chauhan A, Chauhan V, Brown WT (eds) (2010) Autism: oxidative stress, inflammation, and immune abnormalities. CRC Press, Boca RatonGoogle Scholar
  17. Chen H, Chan DC (2009) Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases. Hum Mol Genet 18(R2):R169–R176PubMedCentralPubMedGoogle Scholar
  18. Chez MG, Buchanan CP, Aimonovitch MC, Becker M, Schaefer K, Black C et al (2002) Double-blind, placebo-controlled study of l-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 17(11):833–837PubMedGoogle Scholar
  19. Clay HB, Sillivan S, Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29(3):311–324Google Scholar
  20. Condie J, Goldstein J, Wainwright MS (2010) Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46, XY male with a de novo MECP2 gene mutation. J Child Neurol 25(5):633–636PubMedGoogle Scholar
  21. Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T et al (2006) Brief report: high frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord 36(8):1137–1140PubMedGoogle Scholar
  22. Cotter D, Guda P, Fahy E, Subramaniam S (2004) MitoProteome: mitochondrial protein sequence database and annotation system. Nucleic Acids Res 32(Database issue):D463–D467PubMedCentralPubMedGoogle Scholar
  23. Cox CE (2012) Persistent systemic inflammation in chronic critical illness. Respir Care 57(6):859–864, discussion 864–856PubMedGoogle Scholar
  24. Cuturic M, Abramson RK, Moran RR, Hardin JW (2011) Carnitine and metabolic correlates in hospitalized psychiatric patients: a follow-through report. J Psychiatr Pract 17(1):35–40PubMedGoogle Scholar
  25. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61(5):450–458PubMedGoogle Scholar
  26. Dai DF, Rabinovitch PS, Ungvari Z (2012) Mitochondria and cardiovascular aging. Circ Res 110(8):1109–1124PubMedGoogle Scholar
  27. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46–56PubMedCentralPubMedGoogle Scholar
  28. DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348(26):2656–2668PubMedGoogle Scholar
  29. Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L (1993) A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry 17(5):765–774PubMedGoogle Scholar
  30. Enns GM (2003) The contribution of mitochondria to common disorders. Mol Genet Metab 80(1–2):11–26PubMedGoogle Scholar
  31. Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H (2010) 5q14.3 deletion manifesting as mitochondrial disease and autism: case report. J Child Neurol 25(10):1232–1235PubMedGoogle Scholar
  32. Fahmy SF, El-hamamsy MH, Zaki OK, Badary OA (2013) l-Carnitine supplementation improves the behavioral symptoms in autistic children. Res Autism Spectr Disord 7(1):159–166Google Scholar
  33. Fattal O, Link J, Quinn K, Cohen BH, Franco K (2007) Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr 12(6):429–438PubMedGoogle Scholar
  34. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E (2012) Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322(1–2):254–262PubMedGoogle Scholar
  35. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A, Miranda M, Mari M et al (1997) GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am J Physiol 273(1 Pt 1):G7–G17PubMedGoogle Scholar
  36. Fernandez-Checa JC, Garcia-Ruiz C, Colell A, Morales A, Mari M, Miranda M et al (1998) Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8(1–2):7–11PubMedGoogle Scholar
  37. Filiano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia J (2002) Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 17(6):435–439Google Scholar
  38. Filipek PA, Juranek J, Smith M, Mays LZ, Ramos ER, Bocian M et al (2003) Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 53(6):801–804PubMedGoogle Scholar
  39. Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ (2004) Relative carnitine deficiency in autism. J Autism Dev Disord 34(6):615–623PubMedGoogle Scholar
  40. Finsterer J (2006) Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 114(4):217–238PubMedGoogle Scholar
  41. Finsterer J (2009) Mitochondrial disorders, cognitive impairment and dementia. J Neurol Sci 283(1–2):143–148PubMedGoogle Scholar
  42. Forester BP, Berlow YA, Harper DG, Jensen JE, Lange N, Froimowitz MP et al (2010) Age-related changes in brain energetics and phospholipid metabolism. NMR Biomed 23(3):242–250PubMedGoogle Scholar
  43. Forester BP, Zuo CS, Ravichandran C, Harper DG, Du F, Kim S et al (2012) Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression. J Geriatr Psychiatry Neurol 25(1):43–50PubMedGoogle Scholar
  44. Freedenfeld SH, Hamada K, Audhya T, Adams JB (2011) Biochemical effects of ribose and NADH therapy in children with autism. Autism Insights 3:3–13Google Scholar
  45. Frye RE (2009) 15q11.2-13 duplication, mitochondrial dysfunction, and developmental disorders. J Child Neurol 24(10):1316–1320PubMedCentralPubMedGoogle Scholar
  46. Frye RE (2012a) Mitochondrial disease in 22q13 duplication syndrome. J Child Neurol 27(7):942–949PubMedGoogle Scholar
  47. Frye RE (2012b) Novel mitochondrial Cytochrome b gene polymorphisms associated with autism. J Pediatr Neurol 10:35–40Google Scholar
  48. Frye RE, Naviaux RK (2011) Complex IV overactivity in regressive autism. J Pediatr Neurol 9:427–434Google Scholar
  49. Frye RE, Rossignol DA (2011) Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 69((5 Pt 2)):41R–47RPubMedCentralPubMedGoogle Scholar
  50. Gargus JJ, Imtiaz F (2008) Mitochondrial energy-deficient endophenotype in autism. Am J Biochem Biotech 4(2):198–207Google Scholar
  51. Gargus JJ, Lerner MA (1997) Familial autism with primary carnitine deficiency, sudden death, hypotonia and hypochromic anemia. Am J Human Genet 61:A98Google Scholar
  52. Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL et al (2011) A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monit 17(6):PI15–PI23PubMedCentralPubMedGoogle Scholar
  53. Gibson JH, Slobedman B, Harikrishnan KN, Williamson SL, Minchenko D, El-Osta A et al (2010) Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci 11:53PubMedCentralPubMedGoogle Scholar
  54. Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D et al (2000) Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol 15(6):357–361PubMedGoogle Scholar
  55. Grosser E, Hirt U, Janc OA, Menzfeld C, Fischer M, Kempkes B et al (2012) Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome. Neurobiol Dis 48(1):102–114PubMedGoogle Scholar
  56. Haas RH (2010) Autism and mitochondrial disease. Dev Disabil Res Rev 16(2):144–153PubMedGoogle Scholar
  57. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N et al (2007) Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120(6):1326–1333PubMedGoogle Scholar
  58. Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA et al (2012) A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biol Psychiatry 71(11):956–961PubMedGoogle Scholar
  59. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10(1):40–68; image 45PubMedGoogle Scholar
  60. Hopkins SE, Somoza A, Gilbert DL (2010) Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol 25(6):752–756PubMedGoogle Scholar
  61. Inczedy-Farkas G, Remenyi V, Gal A, Varga Z, Balla P, Udvardy-Meszaros A et al (2012) Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav Brain Funct 8:9PubMedCentralPubMedGoogle Scholar
  62. Iwamoto K, Bundo M, Kato T (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14(2):241–253PubMedGoogle Scholar
  63. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW et al (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80(6):1611–1617PubMedGoogle Scholar
  64. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O et al (2009a) Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89(1):425–430PubMedCentralPubMedGoogle Scholar
  65. James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O et al (2009b) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 23(8):2374–2383PubMedCentralPubMedGoogle Scholar
  66. Jou SH, Chiu NY, Liu CS (2009) Mitochondrial dysfunction and psychiatric disorders. Chang Gung Med J 32(4):370–379PubMedGoogle Scholar
  67. Ju Seok R, Sook Joung L, In Young S, Tae Sung K, Han Ik Y (2009) Depressive episode with catatonic features in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). J Child Neurol 24(10):1307–1309Google Scholar
  68. Kato T, Takahashi Y (1996) Deletion of leukocyte mitochondrial DNA in bipolar disorder. J Affect Disord 37(2–3):67–73PubMedGoogle Scholar
  69. Kato C, Umekage T, Tochigi M, Otowa T, Hibino H, Ohtani T et al (2004) Mitochondrial DNA polymorphisms and extraversion. Am J Med Genet B Neuropsychiatr Genet 128B(1):76–79PubMedGoogle Scholar
  70. Kato M, Nakamura M, Ichiba M, Tomiyasu A, Shimo H, Higuchi I, Ueno S, Sano A (2011) Mitochondrial DNA deletion mutations in patients with neuropsychiatric symptoms. Neurosci Res 69(4):331–336Google Scholar
  71. Kaufman KR, Zuber N, Rueda-Lara MA, Tobia A (2010) MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review. Epilepsy Behav 18(4):494–497PubMedGoogle Scholar
  72. Kleinman JE, Law AJ, Lipska BK, Hyde TM, Ellis JK, Harrison PJ et al (2011) Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 69(2):140–145PubMedGoogle Scholar
  73. Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S et al (2009) Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord 114(1–3):327–332PubMedGoogle Scholar
  74. Komulainen T, Hinttala R, Karppa M, Pajunen L, Finnila S, Tuominen H et al (2010) POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype. BMC Neurol 10:29PubMedCentralPubMedGoogle Scholar
  75. Lacey CJ, Salzberg MR (2008) Obsessive-compulsive disorder with mitochondrial disease. Psychosomatics 49(6):540–542PubMedGoogle Scholar
  76. Lambert AJ, Brand MD (2004) Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J 382(Pt 2):511–517PubMedCentralPubMedGoogle Scholar
  77. Laszlo A, Horvath E, Eck E, Fekete M (1994) Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin Chim Acta 229(1–2):205–207PubMedGoogle Scholar
  78. Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119(6):873–887PubMedGoogle Scholar
  79. Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF (2002) High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer’s disease brain. Hum Mol Genet 11(2):133–145PubMedGoogle Scholar
  80. Mancuso M, Ricci G, Choub A, Filosto M, DiMauro S, Davidzon G et al (2008) Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family. J Affect Disord 106(1–2):173–177PubMedGoogle Scholar
  81. Mancuso M, Orsucci D, Ienco EC, Pini E, Choub A, Siciliano G (2013) Psychiatric involvement in adult patients with mitochondrial disease. Neurol Sci 34(1):71–74Google Scholar
  82. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15(9):1437–1449PubMedGoogle Scholar
  83. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al (2012) Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13(5):293–307PubMedGoogle Scholar
  84. Marazziti D, Baroni S, Picchetti M, Landi P, Silvestri S, Vatteroni E et al (2011) Mitochondrial alterations and neuropsychiatric disorders. Curr Med Chem 18(30):4715–4721PubMedGoogle Scholar
  85. Marazziti D, Baroni S, Picchetti M, Landi P, Silvestri S, Vatteroni E et al (2012) Psychiatric disorders and mitochondrial dysfunctions. Eur Rev Med Pharmacol Sci 16(2):270–275PubMedGoogle Scholar
  86. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Sarnat HB (1999) Skeletal muscle mitochondrial defects in nonspecific neurologic disorders. Pediatr Neurol 21(2):538–542PubMedGoogle Scholar
  87. Mattson MP (2007) Mitochondrial regulation of neuronal plasticity. Neurochem Res 32(4–5):707–715PubMedGoogle Scholar
  88. Mattson MP, Liu D (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med 2(2):215–231PubMedGoogle Scholar
  89. Mostafa GA, El-Gamal HA, El-Wakkad ASE, El-Shorbagy OE, Hamza MM (2005) Polyunsaturated fatty acids, carnitine and lactate as biological markers of brain energy in autistic children. Int J Child Neuropsychiatr 2(2):179–188Google Scholar
  90. Munnich A, Rustin P (2001) Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 106(1):4–17PubMedGoogle Scholar
  91. Napoli E, Ross-Inta C, Wong S, Hung C, Fujisawa Y, Sakaguchi D et al (2012) Mitochondrial dysfunction in Pten Haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One 7(8):e42504PubMedCentralPubMedGoogle Scholar
  92. Naudi A, Jove M, Ayala V, Cassanye A, Serrano J, Gonzalo H et al (2012) Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp Diabetes Res 2012:696215PubMedCentralPubMedGoogle Scholar
  93. Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11(6):851–876Google Scholar
  94. Nissenkorn A, Zeharia A, Lev D, Watemberg N, Fattal-Valevski A, Barash V et al (2000) Neurologic presentations of mitochondrial disorders. J Child Neurol 15(1):44–48PubMedGoogle Scholar
  95. Oliveira G, Diogo L, Grazina M, Garcia P, Ataide A, Marques C et al (2005) Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47(3):185–189PubMedGoogle Scholar
  96. Oliveira G, Ataide A, Marques C, Miguel TS, Coutinho AM, Mota-Vieira L et al (2007) Epidemiology of autism spectrum disorder in Portugal: prevalence, clinical characterization, and medical conditions. Dev Med Child Neurol 49(10):726–733PubMedGoogle Scholar
  97. Orhan N, Kucukali CI, Cakir U, Seker N, Aydin M (2012) Genetic variants in nuclear-encoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders. J Psychiatr Res 46(2):212–218PubMedGoogle Scholar
  98. Pagano G, Castello G (2012) Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Exp Med Biol 724:291–299PubMedGoogle Scholar
  99. Pallardo FV, Lloret A, Lebel M, d’Ischia M, Cogger VC, Le Couteur DG et al (2010) Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 11(4):401–419PubMedGoogle Scholar
  100. Pancrudo J, Shanske S, Coku J, Lu J, Mardach R, Akman O et al (2007) Mitochondrial myopathy associated with a novel mutation in mtDNA. Neuromuscul Disord 17(8):651–654PubMedCentralPubMedGoogle Scholar
  101. Pastural E, Ritchie S, Lu Y, Jin W, Kavianpour A, Khine Su-Myat K et al (2009) Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fatty Acids 81(4):253–264PubMedGoogle Scholar
  102. Poling JS, Frye RE, Shoffner J, Zimmerman AW (2006) Developmental regression and mitochondrial dysfunction in a child with autism. J Child Neurol 21(2):170–172PubMedCentralPubMedGoogle Scholar
  103. Pons R, Andreu AL, Checcarelli N, Vila MR, Engelstad K, Sue CM et al (2004) Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 144(1):81–85PubMedGoogle Scholar
  104. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL (2009) Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34(6):1021–1029PubMedGoogle Scholar
  105. Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EM, Doorn JA et al (2009) Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 112(1):4–16PubMedCentralPubMedGoogle Scholar
  106. Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ et al (2009) Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 4(3):e4913PubMedCentralPubMedGoogle Scholar
  107. Rossignol DA (2009) Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry 21(4):213–236PubMedGoogle Scholar
  108. Rossignol DA, Bradstreet JJ (2008) Evidence of mitochondrial dysfunction in autism and implications for treatment. Am J Biochem Biotech 4(2):208–217Google Scholar
  109. Rossignol DA, Frye RE (2011) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17(3):290–314PubMedCentralPubMedGoogle Scholar
  110. Rossignol DA, Frye RE (2012) A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 17(4):389–401PubMedCentralPubMedGoogle Scholar
  111. Salsano E, Giovagnoli AR, Morandi L, Maccagnano C, Lamantea E, Marchesi C et al (2011) Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291 T > C MELAS mutation. J Neurol Sci 300(1–2):165–168PubMedGoogle Scholar
  112. Scaglia F (2010) The role of mitochondrial dysfunction in psychiatric disease. Dev Disabil Res Rev 16(2):136–143PubMedGoogle Scholar
  113. Scaglia F, Zhang S, Tan Z, Fouladi N, Schmitt E, Wong L-J (2009) Prevalence of autism spectrum disorders in subjects with definite diagnosis of mitochondrial cytopathies. In: The American Society of Human Genetics 59th annual meeting. Honolulu, p 22Google Scholar
  114. Schreiber H (2012) Pilot study on executive function and adaptive skills in adolescents and young adults with mitochondrial disease. J Child Neurol 27(12):1506–1516PubMedGoogle Scholar
  115. Schuelke M, Krude H, Finckh B, Mayatepek E, Janssen A, Schmelz M et al (2002) Septo-optic dysplasia associated with a new mitochondrial cytochrome b mutation. Ann Neurol 51(3):388–392PubMedGoogle Scholar
  116. Sequeira A, Martin MV, Rollins B, Moon EA, Bunney WE, Macciardi F et al (2012) Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet 3:103PubMedCentralPubMedGoogle Scholar
  117. Shao L, Martin MV, Watson SJ, Schatzberg A, Akil H, Myers RM et al (2008) Mitochondrial involvement in psychiatric disorders. Ann Med 40(4):281–295PubMedCentralPubMedGoogle Scholar
  118. Shinkai T, Nakashima M, Ohmori O, Terao T, Nakamura J, Hiramatsu N et al (2000) Coenzyme Q10 improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report. Aust N Z J Psychiatry 34(6):1034–1035PubMedGoogle Scholar
  119. Shoffner J, Hyams L, Langley GN, Cossette S, Mylacraine L, Dale J et al (2010) Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol 25(4):429–434PubMedGoogle Scholar
  120. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA et al (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273(12):942–947PubMedGoogle Scholar
  121. Su H, Fan W, Coskun PE, Vesa J, Gold JA, Jiang YH et al (2011) Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome. Neurosci Lett 487(2):129–133PubMedCentralPubMedGoogle Scholar
  122. Triggs WJ, Roe CR, Rhead WJ, Hanson SK, Lin SN, Willmore LJ (1992) Neuropsychiatric manifestations of defect in mitochondrial beta oxidation response to riboflavin. J Neurol Neurosurg Psychiatry 55(3):209–211PubMedCentralPubMedGoogle Scholar
  123. Trushina E, McMurray CT (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145(4):1233–1248PubMedGoogle Scholar
  124. Tsao CY, Mendell JR (2007) Autistic disorder in 2 children with mitochondrial disorders. J Child Neurol 22(9):1121–1123PubMedGoogle Scholar
  125. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L (2011) Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry 26(1):45–56PubMedGoogle Scholar
  126. Verge B, Alonso Y, Miralles C, Valero J, Vilella E, Boles RG et al (2012) New evidence for the involvement of mitochondrial inheritance in schizophrenia: results from a cross-sectional study evaluating the risk of illness in relatives of schizophrenia patients. J Clin Psychiatry 73(5):684–690PubMedGoogle Scholar
  127. Vos M, Lauwers E, Verstreken P (2010) Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci 2:139PubMedCentralPubMedGoogle Scholar
  128. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y et al (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105(49):19318–19323PubMedCentralPubMedGoogle Scholar
  129. Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, Mitchell RL et al (2008) Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One 3(11):e3815PubMedCentralPubMedGoogle Scholar
  130. Young TM, Blakely EL, Swalwell H, Carter JE, Kartsounis LD, O’Donovan DG et al (2010) Mitochondrial transfer RNA(Phe) mutation associated with a progressive neurodegenerative disorder characterized by psychiatric disturbance, dementia, and akinesia-rigidity. Arch Neurol 67(11):1399–1402PubMedGoogle Scholar
  131. Zeviani M, Bertagnolio B, Uziel G (1996) Neurological presentations of mitochondrial diseases. J Inherit Metab Dis 19(4):504–520PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Rossignol Medical CenterIrvineUSA
  2. 2.Department of PediatricsArkansas Children’s Hospital Research Institute, University of Arkansas for Medical SciencesLittle RockUSA

Personalised recommendations